Neuritogenesis and neuronal differentiation promoted by 2,4‐dinitrophenol, a novel anti‐amyloidogenic compound
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Neurite outgrowth is a critical event in neuronal development, formation, and remodeling of synapses, response to injury, and regeneration. We examined the effects of 2,4‐dinitrophenol (DNP), a recently described blocker of the aggregation and neurotoxicity of the β‐amyloid peptide, on neurite elongation of central neurons. Morphometric analysis of rat embryo hippocampal and cortical neuronal cultures showed that neurite outgrowth was stimulated by DNP. This effect was accompanied by increases in the neuronal levels of the microtubule‐associated protein tau and of cyclic adenosine 3′,5′ monophosphate (cAMP). DNP also promoted cAMP accumulation, increased tau level, neurite outgrowth, and neuronal differentiation in the mouse neuroblastoma cell line N2A. We show that DNP‐induced differentiation requires activation of the extracellular signal‐regulated kinase (ERK). The finding that DNP promotes neuritogenesis and neuronal differentiation suggests that, in addition to its anti‐amyloidogenic actions, it may be a useful lead compound in the development of novel therapeutic approaches targeting neurite dystrophy and synaptic dysfunction in neurodegenerative pathologies such as Alzheimer's disease. Wasilewska‐Sampaio, A. P., Silveira, M. S., Holub, O., Goecking, R., Gomes, F. C. A., Neto, V. M., Linden, R., Ferreira, S. T., De Felice, F. G. Neuritogenesis and neuronal differentiation promoted by 2,4‐dinitrophenol, a novel anti‐amyloidogenic compound. FASEB J. 19, 1627–1636 (2005)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
Role of tau protein in both physiological and pathological conditions
AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · cited 1×
“By contrast, under pathological conditions (such as in Alzheimer’s disease and other tauopathies), tau undergoes abnormal hyperphosphorylation, resulting in self-aggregation and formation of insoluble cytoplasmic inclusions, which appear to be related to the destabilization of microtubules ( 57 ).”
BackgroundActin Cytoskeleton Regulation in Neuronal Morphogenesis and Structural Plasticity
Luo, L. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.031802.150501 · Cited by 658 · cited 1×
“Some of the known steps involve significant rearrangement of microtubules and their associated proteins, such as MAP2 and tau, and actin-based structures ( 16 ).”
BackgroundGreene, L. A., Liem, R. K., & Shelanski, M. L. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.1.76 · Cited by 206
Cited by
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.029 · Cited by 432
Differentiation of mouse Neuro 2A cells into dopamine neurons
Tremblay, R. G., Sikorska, M., Sandhu, J. K., Lanthier, P., Ribecco-Lutkiewicz, M., & Bani-Yaghoub, M. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.11.004 · Cited by 279
Geisler, J. G. (2019) · Cells · doi:10.3390/cells8030280 · Cited by 104
Liu, D., Zhang, Y., Gharavi, R., Park, H. R., Lee, J., Siddiqui, S., Telljohann, R., Nassar, M. R., Cutler, R. G., Becker, K. G., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13176 · Cited by 68
“It was previously reported that low concentrations of DNP increase cyclic AMP levels in cultured neurons (Wasilewska-Sampaio et al. 2005) which, in addition to Ca2+, would also be expected to activate CREB and up-regulate BDNF expression.”
BackgroundTwo PTP receptors mediate CSPG inhibition by convergent and divergent signaling pathways in neurons
Ohtake, Y., Wong, D., Abdul-Muneer, P. M., Selzer, M. E., & Li, S. (2016) · Scientific Reports · doi:10.1038/srep37152 · Cited by 59
Hu, S., Cui, W., Mak, S., Xu, D., Hu, Y., Tang, J., Choi, C., Lee, M., Pang, Y., & Han, Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00108 · Cited by 24
Metadata
- Authors
- Wasilewska‐Sampaio, A. P., Silveira, M. S., Holub, O., Goecking, R., Gomes, F. C. A., Neto, V. M., Linden, R., Ferreira, S. T., & De Felice, F. G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-10
- Volume
- 19
- Issue
- 12
- Pages
- 1627-1636
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2070644907
- Cited by
- 45
- References
- 4
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.